Amit Munshi

Président chez SENSORION Fortune : 4 M $ au 31/05/2026

Profil

Mr. Amit D.
Munshi is a Chairman at Sensorion SA, an Independent Chairman at Inhibikase Therapeutics, Inc., a Chairman at Zura Bio Ltd. and a Co-Chairman at Enterprise Therapeutics Ltd. He is on the Board of Directors at Arcutis Biotherapeutics, Inc., Adrista, Inc., Onebiopharma, Inc. and Pulmatrix Operating Co., Inc. Mr. Munshi was previously employed as a Chief Executive Officer & Director by Orna Therapeutics, Inc., a Chief Executive Officer & Director by ReNAgade Therapeutics, Inc., an Independent Director by Social Capital Suvretta Holdings Corp.
IV, an Independent Director by Damora Therapeutics, Inc., an Independent Director by Pulmatrix, Inc., a President & Chief Executive Officer by Arena Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Zalicus, Inc., a President, Chief Executive Officer & Director by EPIRUS Biopharmaceuticals, Inc., a Chief Executive Officer by EPIRUS Biopharmaceuticals, Inc. /Old/, a President & Chief Executive Officer by Percivia LLC, a Chief Business Officer by Kythera Biopharmaceuticals Inc, a General Manager-Nephrology Europe by Amgen, Inc., a Chairman-Management Board by Arena Pharmaceuticals GmbH, a Principal by Astra Merck, Inc., a Chairman by Cytrellis Biosystems, Inc., a Principal by Iolab Corp., and a Chief Business Officer by Johnson & Johnson.
He also served on the board at Oxeia Biopharmaceuticals, Inc., LungLife AI, Inc., JATT Acquisition Corp.
and Nephrian, Inc. He received his undergraduate degree from the University of California, Riverside and an MBA from Peter F Drucker & Masatoshi Ito Graduate School of Management.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
ZURA BIO LIMITED CLASS A 0,82 %	20/04/2026	777 384 ( 0,82 % )	3 M $	31/05/2026
INHIBIKASE THERAPEUTICS, INC. 0,31 %	15/04/2026	403 176 ( 0,31 % )	705 558 $	31/05/2026
ARCUTIS BIOTHERAPEUTICS INC 0 %	05/06/2026	4 021 ( 0 % )	86 291 $	31/05/2026

Dernières actualités sur Amit Munshi

08/12	Arcutis renforce son conseil d'administration avec la nomination d'Amit Munshi	RE
02/04/25	Sensorion : nouveau président du conseil nommé
02/04/25	Sensorion : renforce sa gouvernance

Postes actifs de Amit Munshi

Sociétés	Poste	Début
ZURA BIO LIMITED	Président	01/03/2023
INHIBIKASE THERAPEUTICS, INC.	Président	14/02/2025
SENSORION	Président	01/04/2025
ARCUTIS BIOTHERAPEUTICS, INC.	Directeur/Membre du Conseil	04/12/2025
Onebiopharma, Inc.	Directeur/Membre du Conseil	-
Pulmatrix Operating Co., Inc.	Directeur/Membre du Conseil	-
Enterprise Therapeutics Ltd.	Président	01/01/2020
Adrista, Inc.	Directeur/Membre du Conseil	-

Anciens postes connus de Amit Munshi

Sociétés	Poste	Fin
DAMORA THERAPEUTICS, INC.	Président	-
░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░
░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░ ░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░